Type 2 diabetes and the circadian rhythm 16
Type 2 diabetes has become one of the most important health problems of 17 modern society, affecting millions of people worldwide. Obesity and excessive weight 18 gain play a major role in the onset of diabetes, along with other risk factors including 19 genetics and lack of physical activity. In recent years, circadian disturbances have also 20 been identified as contributors to this metabolic disease. Alterations in circadian rhythm 21 derived from our current lifestyle, such as mistimed sleeping, shift-working, or eating at 22 abnormal night time hours, have been related to type 2 diabetes, obesity and metabolic 23 syndrome [1] [2] [3] . The discovery of these associations opens new possibilities for the 24 design of novel treatments for these metabolic disorders based on the appropriate 25 alignment or resetting of the circadian system [4] [5] [6] . In the case of type 2 diabetes, its 26 association to circadian disruption was originally related to an altered function of the 27 central clock located in the hypothalamus. However, recent findings show that this 28 disease can also be attributed to an impaired function of the endocrine pancreatic clock 29 [7] [8] [9] [10] . Thus, the study of the pancreatic clock biology is important not only to 30 understand circadian rhythms and their relationship with metabolism, but also to 31 develop tools for the prevention and therapy of metabolic diseases such as type 2 32 diabetes. 33 34
Central and peripheral clocks 35
In mammals, the central pacemaker is located in the suprachiasmatic nuclei 36 (SCN) in the hypothalamus. It is controlled by a transcriptional/translational 37 autoregulatory feedback loop involving a set of clock genes ( Figure 1 ). The core clock 38 is composed of the transcription factors circadian locomotor output cycles kaput 39 (CLOCK) and brain and muscle Arnt-like protein-1 (BMAL1), which bind to E-box 40 enhancers in the period (Per) and cryptochrome (Cry) promoters, producing PER and 41 CRY expression [11, 12] . PER and CRY proteins interact to form a complex that 42 translocates to the nucleus and inhibits its own CLOCK:BMAL1-induced transcription. 43
Phosphorylation of both proteins can also trigger their degradation by 26S proteasomes. 44
The turnover of PER and CRY allows this cycle to continue. This clock network forms 45 a self-sustained feed-back mechanism with an oscillatory pattern of approximately 24 46 hours ( Figure 1 ). Several proteins encoded by clock genes regulate the expression of 47 Animal models with manipulated clock genes have revealed that circadian 116 rhythms have a key regulatory function in metabolism and glucose homeostasis. These 117 animal models have also shown that impaired function of clock genes may result in 118 prediabetic conditions or overt diabetes. Some evidence of this was first found in Clock 119 mutant mice studies [48] . These mice had disrupted rhythms in feeding and locomotor 120 activity, hyperphagia, hyperlipidemia, hyperglycemia and hypoinsulinemia. 2). Oxidative stress prevention or UCP2 suppression were able to reverse these defects. 234
Additionally, it was shown that the key antioxidant regulatory factor Nrf2 was a direct 235 target of BMAL1. In agreement with these reports, selective pancreas deletion of Bmal1 236 also produced glucose intolerance and defective insulin secretion in mice and isolated 237 islets [86] . tissue to induce glucose uptake, and in the liver to reduce hepatic glucose production. 421
These processes result in decreased plasma glucose levels. In contrast, glucagon mainly 422 binds to liver receptors, activating gluconeogenesis and glycogenolysis via the protein 423 kinase A pathway, which allows for an increase in plasma glucose levels. Thus, glucose 424 is maintained within a physiological range by the fine regulation of islet secretion [104] . 425
Type 2 diabetes results from insulin resistance along with impaired beta-cell 426 function. In this condition, insulin action is attenuated, leading to decreased insulin-427 induced glucose uptake in the adipose tissue and muscle as well as enhanced hepatic 428 glucose production [105] . In the majority of individuals, insulin resistance induces a 429 compensatory adaptation in the pancreas, resulting in an augmented beta-cell mass and 430 function to increase insulin release, which ensures the maintenance of normoglycemia. 431
However, when this beta-cell compensation is insufficient, hyperglycemia may 432 progressively develop. This deficient adaptive response can be also accompanied by 433 beta-cell failure and loss. It has been suggested that hyperglucagonemia and alpha-cell 434 dysfunction are also involved in the pathophysiology of type 2 diabetes, and may 435 exacerbate the high plasma glucose levels. 
